Correction: Cost‑effectiveness of finerenone in chronic kidney disease associated with type 2 diabetes in The Netherlands.

IF 10.6 1区医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS

Cardiovascular Diabetology Pub Date : 2025-05-15 DOI:10.1186/s12933-025-02752-2

Sara W Quist, Alexander V van Schoonhoven, Stephan J L Bakker, Michał Pochopień, Maarten J Postma, Jeanni M T van Loon, Jeroen H J Paulissen

引用次数: 0

查看原文本刊更多论文

更正：在荷兰，芬尼酮治疗与2型糖尿病相关的慢性肾脏疾病的成本效益。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Cardiovascular Diabetology 医学-内分泌学与代谢

CiteScore

12.30

自引率

15.10%

发文量

240

审稿时长

1 months

期刊介绍： Cardiovascular Diabetology is a journal that welcomes manuscripts exploring various aspects of the relationship between diabetes, cardiovascular health, and the metabolic syndrome. We invite submissions related to clinical studies, genetic investigations, experimental research, pharmacological studies, epidemiological analyses, and molecular biology research in this field.